人員介紹 - 青島大學(xué)附屬醫(yī)院
青島大學(xué)附屬醫(yī)院是青島市最大省屬綜合性醫(yī)院,國家三級甲等醫(yī)院。擁有4個院區(qū),開放床位3700張。
http://ifkure.cn/yljdryjs
2025-04-05T01:33:24+08:00
青島大學(xué)附屬醫(yī)院
[email protected]
2025澳门资料,管家婆三期必内必中一期,香港内部最精准免费资料
2017-01-20T06:25:34+08:00
2017-01-20T06:25:34+08:00
http://ifkure.cn/yljdryjs/3945-jigourenyuanjieshao-4033
官宣
[email protected]
<p><img src="http://ifkure.cn/images/yljdimage/114-1411021F63T09.png" /></p><p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/照片_62646.jpg" alt="照片_62646.jpg" width="400" height="599" /></p>
<p class="MsoNormal" style="text-indent: 32.0000pt; mso-char-indent-count: 2.0000; text-align: center;" align="center"><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">曹玉,博士,主任藥師,碩士生導(dǎo)師。</span></span><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p class="MsoNormal" style="text-indent: 32.0000pt; mso-char-indent-count: 2.0000; text-align: center;" align="center"><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">青島大學(xué)附屬醫(yī)院臨床試驗(yàn)中心和臨床試驗(yàn)機(jī)構(gòu)副主任,臨床試驗(yàn)中心和臨床試驗(yàn)機(jī)構(gòu)辦公室主任,</span>I<span style="font-family: 宋體;">期臨床研究中心主任。</span></span><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p class="MsoNormal" style="text-indent: 32.0000pt; mso-char-indent-count: 2.0000;"><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">兼任中國藥理學(xué)會藥物臨床試驗(yàn)專業(yè)委員會常務(wù)委員、青年委員會副主任委員兼副秘書長,中國藥學(xué)會藥物臨床評價研究專業(yè)委員會委員,中國抗癌協(xié)會中西醫(yī)整合腫瘤專業(yè)委員會早期臨床試驗(yàn)研究協(xié)作組副組長,中國</span>GCP<span style="font-family: 宋體;">聯(lián)盟早期臨床研究專業(yè)委員會秘書長,中國醫(yī)藥質(zhì)量管理協(xié)會臨床研究質(zhì)量與評價專業(yè)委員會常委,中國藥理學(xué)會定量藥理學(xué)專業(yè)委員會委員,中國醫(yī)藥教育協(xié)會藥物臨床試驗(yàn)研究標(biāo)準(zhǔn)評價分會常務(wù)委員,中國藥理學(xué)會定量藥理學(xué)專業(yè)委員會委員,山東省醫(yī)學(xué)會物臨床研究與評價分會副主任委員,山東省藥學(xué)會藥物臨床評價研究專業(yè)委員會副主任委員,山東藥理學(xué)會藥物臨床試驗(yàn)倫理專業(yè)委員會副主任委員。</span></span><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p class="MsoNormal" style="text-indent: 32.0000pt; mso-char-indent-count: 2.0000;"><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">負(fù)責(zé)臨床試驗(yàn)管理與開展</span>17<span style="font-family: 宋體;">年,管理臨床試驗(yàn)研究項(xiàng)目400</span><span style="font-family: 宋體;">余項(xiàng),主持BE/I</span><span style="font-family: 宋體;">期臨床試驗(yàn)項(xiàng)目100</span><span style="font-family: 宋體;">余項(xiàng),負(fù)責(zé)國家科技重大專項(xiàng)GCP</span><span style="font-family: 宋體;">平臺課題2</span><span style="font-family: 宋體;">項(xiàng),發(fā)表SCI</span><span style="font-family: 宋體;">收錄論文16</span><span style="font-family: 宋體;">篇。</span></span><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p><img src="http://ifkure.cn/images/yljdimage/114-1411021F63T09.png" /></p><p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/照片_62646.jpg" alt="照片_62646.jpg" width="400" height="599" /></p>
<p class="MsoNormal" style="text-indent: 32.0000pt; mso-char-indent-count: 2.0000; text-align: center;" align="center"><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">曹玉,博士,主任藥師,碩士生導(dǎo)師。</span></span><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p class="MsoNormal" style="text-indent: 32.0000pt; mso-char-indent-count: 2.0000; text-align: center;" align="center"><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">青島大學(xué)附屬醫(yī)院臨床試驗(yàn)中心和臨床試驗(yàn)機(jī)構(gòu)副主任,臨床試驗(yàn)中心和臨床試驗(yàn)機(jī)構(gòu)辦公室主任,</span>I<span style="font-family: 宋體;">期臨床研究中心主任。</span></span><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p class="MsoNormal" style="text-indent: 32.0000pt; mso-char-indent-count: 2.0000;"><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">兼任中國藥理學(xué)會藥物臨床試驗(yàn)專業(yè)委員會常務(wù)委員、青年委員會副主任委員兼副秘書長,中國藥學(xué)會藥物臨床評價研究專業(yè)委員會委員,中國抗癌協(xié)會中西醫(yī)整合腫瘤專業(yè)委員會早期臨床試驗(yàn)研究協(xié)作組副組長,中國</span>GCP<span style="font-family: 宋體;">聯(lián)盟早期臨床研究專業(yè)委員會秘書長,中國醫(yī)藥質(zhì)量管理協(xié)會臨床研究質(zhì)量與評價專業(yè)委員會常委,中國藥理學(xué)會定量藥理學(xué)專業(yè)委員會委員,中國醫(yī)藥教育協(xié)會藥物臨床試驗(yàn)研究標(biāo)準(zhǔn)評價分會常務(wù)委員,中國藥理學(xué)會定量藥理學(xué)專業(yè)委員會委員,山東省醫(yī)學(xué)會物臨床研究與評價分會副主任委員,山東省藥學(xué)會藥物臨床評價研究專業(yè)委員會副主任委員,山東藥理學(xué)會藥物臨床試驗(yàn)倫理專業(yè)委員會副主任委員。</span></span><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p class="MsoNormal" style="text-indent: 32.0000pt; mso-char-indent-count: 2.0000;"><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">負(fù)責(zé)臨床試驗(yàn)管理與開展</span>17<span style="font-family: 宋體;">年,管理臨床試驗(yàn)研究項(xiàng)目400</span><span style="font-family: 宋體;">余項(xiàng),主持BE/I</span><span style="font-family: 宋體;">期臨床試驗(yàn)項(xiàng)目100</span><span style="font-family: 宋體;">余項(xiàng),負(fù)責(zé)國家科技重大專項(xiàng)GCP</span><span style="font-family: 宋體;">平臺課題2</span><span style="font-family: 宋體;">項(xiàng),發(fā)表SCI</span><span style="font-family: 宋體;">收錄論文16</span><span style="font-family: 宋體;">篇。</span></span><span style="mso-spacerun: 'yes'; font-family: 宋體; font-size: 16.0000pt; mso-font-kerning: 1.0000pt;"></span></p>
王晨靜
2017-01-20T06:25:34+08:00
2017-01-20T06:25:34+08:00
http://ifkure.cn/yljdryjs/3942-jigourenyuanjieshao-4036
官宣
[email protected]
<p><img src="http://ifkure.cn/images/yljdimage/114-1411021FZ1S6.png" /></p><div><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/照片_2a145.jpg" alt="照片_2a145.jpg" width="400" height="560" /></div>
<div style="text-align: center;"><img style="width: 184px; height: 240px;" src="http://ifkure.cn//ks/uploads/allimg/141102/114-1411021FZ1S6.png" alt="" /></div>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">副主任藥師,藥理學(xué)博士,機(jī)構(gòu)辦秘書、一期臨床研究中心</span><span style="font-family: Calibri;">QA</span><span style="font-family: 宋體;">。從事藥物</span><span style="font-family: Calibri;">/</span><span style="font-family: 宋體;">器械臨床試驗(yàn)質(zhì)量控制與保證等相關(guān)工作,負(fù)責(zé)項(xiàng)目立項(xiàng)、合同審核、質(zhì)量控制及結(jié)題等工作。作為</span><span style="font-family: Calibri;">QA</span><span style="font-family: 宋體;">,每年參與二十余項(xiàng)一期臨床試驗(yàn)。作為國家局</span><span style="font-family: Calibri;">CFDI GCP</span><span style="font-family: 宋體;">檢查員每年多次參與項(xiàng)目核查,資格認(rèn)定檢查及省局組織的日常監(jiān)督檢查。目前發(fā)表</span><span style="font-family: Calibri;">SCI</span><span style="font-family: 宋體;">收錄論文多篇。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p><img src="http://ifkure.cn/images/yljdimage/114-1411021FZ1S6.png" /></p><div><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/照片_2a145.jpg" alt="照片_2a145.jpg" width="400" height="560" /></div>
<div style="text-align: center;"><img style="width: 184px; height: 240px;" src="http://ifkure.cn//ks/uploads/allimg/141102/114-1411021FZ1S6.png" alt="" /></div>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">副主任藥師,藥理學(xué)博士,機(jī)構(gòu)辦秘書、一期臨床研究中心</span><span style="font-family: Calibri;">QA</span><span style="font-family: 宋體;">。從事藥物</span><span style="font-family: Calibri;">/</span><span style="font-family: 宋體;">器械臨床試驗(yàn)質(zhì)量控制與保證等相關(guān)工作,負(fù)責(zé)項(xiàng)目立項(xiàng)、合同審核、質(zhì)量控制及結(jié)題等工作。作為</span><span style="font-family: Calibri;">QA</span><span style="font-family: 宋體;">,每年參與二十余項(xiàng)一期臨床試驗(yàn)。作為國家局</span><span style="font-family: Calibri;">CFDI GCP</span><span style="font-family: 宋體;">檢查員每年多次參與項(xiàng)目核查,資格認(rèn)定檢查及省局組織的日常監(jiān)督檢查。目前發(fā)表</span><span style="font-family: Calibri;">SCI</span><span style="font-family: 宋體;">收錄論文多篇。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
李欣
2017-01-20T06:25:34+08:00
2017-01-20T06:25:34+08:00
http://ifkure.cn/yljdryjs/3939-jigourenyuanjieshao-4040
官宣
[email protected]
<p><img src="http://ifkure.cn/images/yljdimage/114-1411021G211315.png" /></p><div style="text-align: center;">
<p><img src="http://ifkure.cn/images/news/2021/07/16/李欣_b625c.jpg" alt="李欣_b625c.jpg" width="400" height="389" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">李欣,醫(yī)學(xué)博士,臨床試驗(yàn)中心質(zhì)控員,主要從事臨床試驗(yàn)管理工作,及神經(jīng)系統(tǒng)疾病的基礎(chǔ)與藥理學(xué)研究。</span></span></p>
</div>
<p><img src="http://ifkure.cn/images/yljdimage/114-1411021G211315.png" /></p><div style="text-align: center;">
<p><img src="http://ifkure.cn/images/news/2021/07/16/李欣_b625c.jpg" alt="李欣_b625c.jpg" width="400" height="389" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">李欣,醫(yī)學(xué)博士,臨床試驗(yàn)中心質(zhì)控員,主要從事臨床試驗(yàn)管理工作,及神經(jīng)系統(tǒng)疾病的基礎(chǔ)與藥理學(xué)研究。</span></span></p>
</div>
柳艷平
2017-01-20T06:25:34+08:00
2017-01-20T06:25:34+08:00
http://ifkure.cn/yljdryjs/3949-jigourenyuanjieshao-4039
官宣
[email protected]
<p><img src="http://ifkure.cn/images/yljdimage/114-1411021G10HS.png" /></p><div><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/柳艷平_c0dae.jpg" alt="柳艷平_c0dae.jpg" /></div>
<div style="text-align: center;"><span style="font-size: 14px;"><img style="width: 176px; height: 240px;" src="http://ifkure.cn//ks/uploads/allimg/141102/114-1411021G10HS.png" alt="" /></span></div>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">柳艷平,主管藥師,臨床試驗(yàn)中心質(zhì)控員,一期臨床試驗(yàn)中心研究藥師。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p><img src="http://ifkure.cn/images/yljdimage/114-1411021G10HS.png" /></p><div><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/柳艷平_c0dae.jpg" alt="柳艷平_c0dae.jpg" /></div>
<div style="text-align: center;"><span style="font-size: 14px;"><img style="width: 176px; height: 240px;" src="http://ifkure.cn//ks/uploads/allimg/141102/114-1411021G10HS.png" alt="" /></span></div>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">柳艷平,主管藥師,臨床試驗(yàn)中心質(zhì)控員,一期臨床試驗(yàn)中心研究藥師。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
時萍
2021-07-16T07:13:43+08:00
2021-07-16T07:13:43+08:00
http://ifkure.cn/yljdryjs/4175-2021-07-16-07-13-43
官宣
[email protected]
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/時萍_c6e6f.jpg" alt="時萍_c6e6f.jpg" width="400" height="400" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">本科,主管藥師,國家藥物臨床試驗(yàn)機(jī)構(gòu)藥品管理員,兼任青島市生理科學(xué)學(xué)會臨床研究與評價專業(yè)委員會委員。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/時萍_c6e6f.jpg" alt="時萍_c6e6f.jpg" width="400" height="400" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">本科,主管藥師,國家藥物臨床試驗(yàn)機(jī)構(gòu)藥品管理員,兼任青島市生理科學(xué)學(xué)會臨床研究與評價專業(yè)委員會委員。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
陶野
2021-07-16T07:15:22+08:00
2021-07-16T07:15:22+08:00
http://ifkure.cn/yljdryjs/4177-2021-07-16-07-15-22
官宣
[email protected]
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/照片_5bdd9.jpg" alt="照片_5bdd9.jpg" width="400" height="560" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">醫(yī)學(xué)碩士,主管藥師,機(jī)構(gòu)辦質(zhì)控員、藥物管理員,共發(fā)表</span><span style="font-family: Calibri;">SCI</span><span style="font-family: 宋體;">收錄論文</span><span style="font-family: Calibri;">6</span><span style="font-family: 宋體;">篇,其中第</span><span style="font-family: Calibri;">1</span><span style="font-family: 宋體;">作者</span><span style="font-family: Calibri;">2</span><span style="font-family: 宋體;">篇。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/照片_5bdd9.jpg" alt="照片_5bdd9.jpg" width="400" height="560" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">醫(yī)學(xué)碩士,主管藥師,機(jī)構(gòu)辦質(zhì)控員、藥物管理員,共發(fā)表</span><span style="font-family: Calibri;">SCI</span><span style="font-family: 宋體;">收錄論文</span><span style="font-family: Calibri;">6</span><span style="font-family: 宋體;">篇,其中第</span><span style="font-family: Calibri;">1</span><span style="font-family: 宋體;">作者</span><span style="font-family: Calibri;">2</span><span style="font-family: 宋體;">篇。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
蔣鑫
2021-07-16T07:08:16+08:00
2021-07-16T07:08:16+08:00
http://ifkure.cn/yljdryjs/4171-2021-07-16-07-08-16
官宣
[email protected]
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/照片_652e2.jpg" alt="照片_652e2.jpg" width="400" height="532" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">主管藥師,藥物化學(xué)碩士,臨床試驗(yàn)中心檔案管理員,</span><span style="font-family: Calibri;">I</span><span style="font-family: 宋體;">期臨床研究中心助理研究者、生物樣本管理員。參與創(chuàng)新藥</span><span style="font-family: Calibri;">I</span><span style="font-family: 宋體;">期臨床試驗(yàn)和生物等效性試驗(yàn)</span><span style="font-family: Calibri;">50</span><span style="font-family: 宋體;">余項(xiàng),其中作為助理研究者參與實(shí)施</span><span style="font-family: Calibri;">16</span><span style="font-family: 宋體;">項(xiàng)。</span></span></p>
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/照片_652e2.jpg" alt="照片_652e2.jpg" width="400" height="532" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">主管藥師,藥物化學(xué)碩士,臨床試驗(yàn)中心檔案管理員,</span><span style="font-family: Calibri;">I</span><span style="font-family: 宋體;">期臨床研究中心助理研究者、生物樣本管理員。參與創(chuàng)新藥</span><span style="font-family: Calibri;">I</span><span style="font-family: 宋體;">期臨床試驗(yàn)和生物等效性試驗(yàn)</span><span style="font-family: Calibri;">50</span><span style="font-family: 宋體;">余項(xiàng),其中作為助理研究者參與實(shí)施</span><span style="font-family: Calibri;">16</span><span style="font-family: 宋體;">項(xiàng)。</span></span></p>
林萍萍
2021-07-16T07:10:39+08:00
2021-07-16T07:10:39+08:00
http://ifkure.cn/yljdryjs/4173-2021-07-16-07-10-39
官宣
[email protected]
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/林萍萍_b4b5e.jpg" alt="林萍萍_b4b5e.jpg" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">主管藥師,藥理學(xué)博士。主要從事新藥臨床研究,參與多項(xiàng)創(chuàng)新藥</span><span style="font-family: Calibri;">I</span><span style="font-family: 宋體;">期臨床試驗(yàn),熟悉生物樣本分析方法的建立與確證。目前以第一作者發(fā)表</span><span style="font-family: Calibri;">SCI</span><span style="font-family: 宋體;">收錄論文</span><span style="font-family: Calibri;">4</span><span style="font-family: 宋體;">篇,中文核心期刊論文</span><span style="font-family: Calibri;">3</span><span style="font-family: 宋體;">篇。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/林萍萍_b4b5e.jpg" alt="林萍萍_b4b5e.jpg" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">主管藥師,藥理學(xué)博士。主要從事新藥臨床研究,參與多項(xiàng)創(chuàng)新藥</span><span style="font-family: Calibri;">I</span><span style="font-family: 宋體;">期臨床試驗(yàn),熟悉生物樣本分析方法的建立與確證。目前以第一作者發(fā)表</span><span style="font-family: Calibri;">SCI</span><span style="font-family: 宋體;">收錄論文</span><span style="font-family: Calibri;">4</span><span style="font-family: 宋體;">篇,中文核心期刊論文</span><span style="font-family: Calibri;">3</span><span style="font-family: 宋體;">篇。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
李婷
2021-07-16T07:09:09+08:00
2021-07-16T07:09:09+08:00
http://ifkure.cn/yljdryjs/4172-2021-07-16-07-09-09
官宣
[email protected]
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/李婷_33e67.jpg" alt="李婷_33e67.jpg" width="400" height="491" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">醫(yī)學(xué)碩士,主治醫(yī)師,參與百余項(xiàng)臨床試驗(yàn)項(xiàng)目,熟練掌握常見病、多發(fā)病的診治,在核心期刊發(fā)表多篇論文</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/李婷_33e67.jpg" alt="李婷_33e67.jpg" width="400" height="491" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">醫(yī)學(xué)碩士,主治醫(yī)師,參與百余項(xiàng)臨床試驗(yàn)項(xiàng)目,熟練掌握常見病、多發(fā)病的診治,在核心期刊發(fā)表多篇論文</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
孫菲菲
2021-07-16T07:14:11+08:00
2021-07-16T07:14:11+08:00
http://ifkure.cn/yljdryjs/4176-2021-07-16-07-14-11
官宣
[email protected]
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/照片_eb1eb.jpg" alt="照片_eb1eb.jpg" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">醫(yī)學(xué)碩士,主治醫(yī)師,具有神經(jīng)內(nèi)科專業(yè)十年工作經(jīng)歷,熟練掌握常見病、多發(fā)病的診治,參與臨床試驗(yàn)項(xiàng)目數(shù)十項(xiàng),參與專著編寫一本,在核心期刊發(fā)表論文多篇。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="http://ifkure.cn/images/news/2021/07/16/照片_eb1eb.jpg" alt="照片_eb1eb.jpg" /></p>
<p class="MsoNormal"><span style="mso-spacerun: 'yes'; font-family: 宋體; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"><span style="font-family: 宋體;">醫(yī)學(xué)碩士,主治醫(yī)師,具有神經(jīng)內(nèi)科專業(yè)十年工作經(jīng)歷,熟練掌握常見病、多發(fā)病的診治,參與臨床試驗(yàn)項(xiàng)目數(shù)十項(xiàng),參與專著編寫一本,在核心期刊發(fā)表論文多篇。</span></span><span style="mso-spacerun: 'yes'; font-family: Calibri; mso-fareast-font-family: 宋體; mso-bidi-font-family: 'Times New Roman'; font-size: 10.5000pt; mso-font-kerning: 1.0000pt;"></span></p>